Aila Biotech harnesses a patented gene delivery technology to drive the production of immune-regulating biologics at the site of disease.
Through the use of a delivery system allowing exquisite spatial and temporal control over biologic expression, Aila Biotech can prevent neuroinflammatory damage and pathology progression